Patents by Inventor Divor Kiseljak

Divor Kiseljak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11746360
    Abstract: The present invention provides robust, streamlined, reproducible and highly efficient eukaryotic cell transfection systems and related methods. The highly-efficient systems and methods of the present invention reduce the number of steps required to transfect cells and reduce, e.g., eliminate, the need for specialized equipment. In particular, the systems and related methods afford the ability for streamlining transfection while retaining and improving robust and reproducible transfection efficiencies, cell viability, and/or protein production. Furthermore, the highly-efficient systems and methods of the present invention for transfecting eukaryotic cells also eliminate the need for any specialized or complicated preparation of exogenous nucleic acid, which makes available high throughput and/or large scale transfection.
    Type: Grant
    Filed: February 11, 2020
    Date of Patent: September 5, 2023
    Inventors: Florian M. Wurm, Maria J. Wurm, Maria de Lourdes Rodrigues, Divor Kiseljak, Cedric Bürki, Cyril Pugin, Guillaume Raussin, Julie Heymoz
  • Publication number: 20210340185
    Abstract: Materials and methods for the prevention of Ebola virus are provided. This disclosure is related to vaccine compositions comprising one or more Ebola vims (EBOV) glycoproteins as well as methods of preventing an EBOV infection comprising administering such compositions. In particular, modified EBOV glycoproteins are provided that form trimers and induce an immune response.
    Type: Application
    Filed: August 28, 2019
    Publication date: November 4, 2021
    Inventors: Divor Kiseljak, Florian M. Wurm, Valentina Agnolon, Francois Spertini, Bruno Correia
  • Publication number: 20200263203
    Abstract: The present invention provides robust, streamlined, reproducible and highly efficient eukaryotic cell transfection systems and related methods. The highly-efficient systems and methods of the present invention reduce the number of steps required to transfect cells and reduce, e.g., eliminate, the need for specialized equipment. In particular, the systems and related methods afford the ability for streamlining transfection while retaining and improving robust and reproducible transfection efficiencies, cell viability, and/or protein production. Furthermore, the highly-efficient systems and methods of the present invention for transfecting eukaryotic cells also eliminate the need for any specialized or complicated preparation of exogenous nucleic acid, which makes available high throughput and/or large scale transfection.
    Type: Application
    Filed: February 11, 2020
    Publication date: August 20, 2020
    Inventors: Florian M. Wurm, Maria J. Wurm, Maria de Lourdes Rodrigues, Divor Kiseljak, Cedric Bürki, Cyril Pugin, Guillaume Raussin, Julie Heymoz